Jeffrey B. Halter

发表

Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.

J. Halter, M. Pfeifer, D. Porte, 1981, The Journal of clinical endocrinology and metabolism.

Relationship of islet function to insulin action in human obesity.

J. Halter, D. Porte, W. Ward, 1987, The Journal of clinical endocrinology and metabolism.

Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.

J. Halter, D. Porte, J. C. Beard, 1984, The American journal of physiology.

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.

J. Halter, K. Polonsky, M. Pfeifer, 1983, The New England journal of medicine.

Maturity Onset Diabetes of the Young (MODY)

S. Fajans, Kenneth S. Polonsky, Jeffrey B. Halter, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin.

J. Halter, D. Porte, Jeffrey B. Halter, 1978, The Journal of clinical endocrinology and metabolism.

A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.

J. Halter, D. Porte, R. Robertson, 1976, The Journal of clinical investigation.

Comparative plasma catecholamine and hemodynamic responses to handgrip, cold pressor and supine bicycle exercise testing in normal subjects.

J. Halter, J. Ritchie, A. Hallstrom, 1983, Journal of the American College of Cardiology.

Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.

J. Halter, D. Porte, E. Halar, 1979, Annals of internal medicine.

Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

J. Halter, M. Pfeifer, D. Porte, 1981, Annals of internal medicine.

Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men.

J. Halter, M. Pfeifer, D. Porte, 1984, The American journal of physiology.

Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

J. Halter, M. Pfeifer, L. Harker, 1984, The Journal of clinical investigation.